Mesenchymal stem cells confer chemoresistance in breast cancer via a CD9 dependent mechanism

The development of chemotherapy drug resistance remains a significant barrier for effective therapy in several cancers including breast cancer. Bone marrow-derived mesenchymal stem cells (BMMSCs) have previously been shown to influence tumor progression and the development of chemoresistance. In the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ullah, Mujib, Akbar, Asma, Ng, Nathan Norton, Concepcion, Waldo, Thakor, Avnesh S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544397/
https://www.ncbi.nlm.nih.gov/pubmed/31191817
http://dx.doi.org/10.18632/oncotarget.26952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544397/
https://www.ncbi.nlm.nih.gov/pubmed/31191817
http://dx.doi.org/10.18632/oncotarget.26952

Ejemplares similares